Who is sponsoring NCT06951373?

NCT06951373 is sponsored by Quaid-e-Azam Medical College.

What drugs are being tested in NCT06951373?

Interventions in NCT06951373: Multiple Percutaneous Needle Aspiration (MPNA), Incision and Drainage (ID).

What condition does NCT06951373 study?

NCT06951373 studies Breast Abscess.

Is NCT06951373 still recruiting?

NCT06951373 is currently completed. Last updated 30 April 2025.

Last reviewed 2025-04-30 · How we verify

NCT06951373

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Multiple Percutaneous Needle Aspiration Versus Incision and Drainage in Small Breast Abscesses: Pain, Cosmesis, and Early Breastfeeding Outcomes

Completed NA Last updated 30 April 2025

What this trial tests

NA trial testing Multiple Percutaneous Needle Aspiration (MPNA) in Breast Abscess in 110 participants. Completed in 8 June 2021.

Timeline

9 January 2021

Primary endpoint
8 June 2021

8 June 2021

Quick facts

Lead sponsor	Quaid-e-Azam Medical College
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	110
Start date	9 January 2021
Primary completion	8 June 2021
Estimated completion	8 June 2021
Sites	1 location across Pakistan

Drugs / interventions tested

Multiple Percutaneous Needle Aspiration (MPNA)
Incision and Drainage (ID)

Conditions studied

Breast Abscess — all drugs for Breast Abscess →

Sponsor

Quaid-e-Azam Medical College

Who can join

Adults 18 to 45, female only, with Breast Abscess. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the effectiveness of multiple percutaneous needle aspiration (MPNA) versus incision and drainage (ID) for the management of small breast abscesses in breastfeeding women. The trial evaluates three key outcomes: post-procedure pain levels, cosmetic satisfaction, and the timing of breastfeeding restoration. The study is conducted at the Department of Surgery, Bahawal Victoria Hospital Bahawalpur, enrolling 110 lactating women aged 18-45 years with abscesses ≤5 cm in diameter. Participants were treated with either MPNA or ID based on clinical decision and patient preference. Pain levels were assessed using a standardized scale, cosmetic outcomes were evaluated via patient-reported satisfaction, and breastfeeding restoration was monitored at baseline, one week, and one month post-treatment. Findings indicate that MPNA is associated with lower pain scores, better cosmetic satisfaction, and faster resumption of breastfeeding compared to ID, suggesting MPNA as a preferred first-line treatment for small breast abscesses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Quaid-e-Azam Medical College trials

Trials by the same sponsor.

NCT07102836 — COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY · Phase 2 · recruiting
NCT07254130 — COMPARISON OF MEAN DURATION OF POST OPERATIVE ANALGESIA FOLLOWING ADDITION OF DEXMEDETOMIDINE TO ROPIVACAINE VERSUS PLAI · NA · completed
NCT07200076 — Comparison of Mean Duration of Post Operative Analgesia Following QL-2 Block vs QL-3 Block Using Ropivacain 0.25% in Pat · NA · completed
NCT07050329 — Comparison of Operation Time, Drain Duration, and Seroma Formation After Modified Radical Mastectomy Using Ultrasonic Di · NA · completed
NCT06849232 — A Comparative Study of Platelet-Rich Plasma and Normal Saline Dressings in the Treatment of Chronic Wounds (PRP-NS Wound · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06951373 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Quaid-e-Azam Medical College
Last refreshed: 30 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06951373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing